170 related articles for article (PubMed ID: 28415402)
1. Fattigation-platform theranostic nanoparticles for cancer therapy.
Tran TT; Tran PH; Yoon TJ; Lee BJ
Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():1161-1167. PubMed ID: 28415402
[TBL] [Abstract][Full Text] [Related]
2. Biological evaluation of surface-modified magnetic nanoparticles as a platform for colon cancer cell theranostics.
Moskvin M; Babič M; Reis S; Cruz MM; Ferreira LP; Carvalho MD; Lima SAC; Horák D
Colloids Surf B Biointerfaces; 2018 Jan; 161():35-41. PubMed ID: 29040832
[TBL] [Abstract][Full Text] [Related]
3. Magnetic nanoparticles coated with polyarabic acid demonstrate enhanced drug delivery and imaging properties for cancer theranostic applications.
Patitsa M; Karathanou K; Kanaki Z; Tzioga L; Pippa N; Demetzos C; Verganelakis DA; Cournia Z; Klinakis A
Sci Rep; 2017 Apr; 7(1):775. PubMed ID: 28396592
[TBL] [Abstract][Full Text] [Related]
4. Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications.
Sahoo B; Devi KS; Dutta S; Maiti TK; Pramanik P; Dhara D
J Colloid Interface Sci; 2014 Oct; 431():31-41. PubMed ID: 24980623
[TBL] [Abstract][Full Text] [Related]
5. β-Cyclodextrin conjugated magnetic, fluorescent silica core-shell nanoparticles for biomedical applications.
Badruddoza AZ; Rahman MT; Ghosh S; Hossain MZ; Shi J; Hidajat K; Uddin MS
Carbohydr Polym; 2013 Jun; 95(1):449-57. PubMed ID: 23618292
[TBL] [Abstract][Full Text] [Related]
6. Biocompatibility assessment of sub-5 nm silica-coated superparamagnetic iron oxide nanoparticles in human stem cells and in mice for potential application in nanomedicine.
Ledda M; Fioretti D; Lolli MG; Papi M; Di Gioia C; Carletti R; Ciasca G; Foglia S; Palmieri V; Marchese R; Grimaldi S; Rinaldi M; Lisi A
Nanoscale; 2020 Jan; 12(3):1759-1778. PubMed ID: 31895375
[TBL] [Abstract][Full Text] [Related]
7. Theranostic magnetite cluster@silica@albumin double-shell particles as suitable carriers for water-insoluble drugs and enhanced T2 MR imaging contrast agents.
Maboudi SA; Shojaosadati SA; Aliakbari F; Arpanaei A
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():1485-1492. PubMed ID: 30889683
[TBL] [Abstract][Full Text] [Related]
8. Polyetherimide-grafted Fe₃O₄@SiO2₂ nanoparticles as theranostic agents for simultaneous VEGF siRNA delivery and magnetic resonance cell imaging.
Li T; Shen X; Chen Y; Zhang C; Yan J; Yang H; Wu C; Zeng H; Liu Y
Int J Nanomedicine; 2015; 10():4279-91. PubMed ID: 26170664
[TBL] [Abstract][Full Text] [Related]
9. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution and in vivo performance of fattigation-platform theranostic nanoparticles.
Tran TT; Tran PH; Amin HH; Lee BJ
Mater Sci Eng C Mater Biol Appl; 2017 Oct; 79():671-678. PubMed ID: 28629067
[TBL] [Abstract][Full Text] [Related]
11. Triple Hit with Drug Carriers: pH- and Temperature-Responsive Theranostics for Multimodal Chemo- and Photothermal Therapy and Diagnostic Applications.
Baek S; Singh RK; Kim TH; Seo JW; Shin US; Chrzanowski W; Kim HW
ACS Appl Mater Interfaces; 2016 Apr; 8(14):8967-79. PubMed ID: 26926826
[TBL] [Abstract][Full Text] [Related]
12. Polydopamine-Coated Magnetic Composite Particles with an Enhanced Photothermal Effect.
Zheng R; Wang S; Tian Y; Jiang X; Fu D; Shen S; Yang W
ACS Appl Mater Interfaces; 2015 Jul; 7(29):15876-84. PubMed ID: 26151502
[TBL] [Abstract][Full Text] [Related]
13. Tumor-Targeting Multifunctional Rattle-Type Theranostic Nanoparticles for MRI/NIRF Bimodal Imaging and Delivery of Hydrophobic Drugs.
Jiao Y; Sun Y; Tang X; Ren Q; Yang W
Small; 2015 Apr; 11(16):1962-74. PubMed ID: 25504837
[TBL] [Abstract][Full Text] [Related]
14. Polymeric micelles: Theranostic co-delivery system for poorly water-soluble drugs and contrast agents.
Upponi JR; Jerajani K; Nagesha DK; Kulkarni P; Sridhar S; Ferris C; Torchilin VP
Biomaterials; 2018 Jul; 170():26-36. PubMed ID: 29649747
[TBL] [Abstract][Full Text] [Related]
15. A superparamagnetic polymersome with extremely high T
Liu Q; Song L; Chen S; Gao J; Zhao P; Du J
Biomaterials; 2017 Jan; 114():23-33. PubMed ID: 27837682
[TBL] [Abstract][Full Text] [Related]
16. Polymer-Lipid Hybrid Theranostic Nanoparticles Co-Delivering Ultrasmall Superparamagnetic Iron Oxide and Paclitaxel for Targeted Magnetic Resonance Imaging and Therapy in Atherosclerotic Plaque.
Dong Y; Chen H; Chen C; Zhang X; Tian X; Zhang Y; Shi Z; Liu Q
J Biomed Nanotechnol; 2016 Jun; 12(6):1245-57. PubMed ID: 27319218
[TBL] [Abstract][Full Text] [Related]
17. Superparamagnetic Iron Oxide Nanorod Carriers for Paclitaxel Delivery in the Treatment and Imaging of Colon Cancer in Mice.
Dehvari K; Chen Y; Tsai YH; Tseng SH; Lin KS
J Biomed Nanotechnol; 2016 Sep; 12(9):1734-45. PubMed ID: 29345885
[TBL] [Abstract][Full Text] [Related]
18. Polydopamine-coated magnetic mesoporous silica nanoparticles for multimodal cancer theranostics.
Shi M; Zhang J; Li J; Fan Y; Wang J; Sun W; Yang H; Peng C; Shen M; Shi X
J Mater Chem B; 2019 Jan; 7(3):368-372. PubMed ID: 32254723
[TBL] [Abstract][Full Text] [Related]
19. Two-dimensional magnetic WS2@Fe3O4 nanocomposite with mesoporous silica coating for drug delivery and imaging-guided therapy of cancer.
Yang G; Gong H; Liu T; Sun X; Cheng L; Liu Z
Biomaterials; 2015 Aug; 60():62-71. PubMed ID: 25985153
[TBL] [Abstract][Full Text] [Related]
20. Theranostic, pH-Responsive, Doxorubicin-Loaded Nanoparticles Inducing Active Targeting and Apoptosis for Advanced Gastric Cancer.
Ma H; Liu Y; Shi M; Shao X; Zhong W; Liao W; Xing MM
Biomacromolecules; 2015 Dec; 16(12):4022-31. PubMed ID: 26477267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
